Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

计划入组 446 人 · 首次发布于 2017 年 8 月 7 日

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon

计划入组 13 人 · 首次发布于 2016 年 1 月 7 日

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)

计划入组 12 人 · 首次发布于 2018 年 11 月 8 日

SGS Société Générale de Surveillance SA

Switzerland

TAS

CACI International

SurVeil DCB Shows Comparable Efficacy to IN.PACT Admiral with 75% Lower Paclitaxel Dose in TRANSCEND Trial

World GU 2025 Highlights Advances in Variant Histology Management and Community Oncology Care for Genitourinary Cancers

Eisai's Remitoro Clears Post-Marketing Surveillance Requirements for T-Cell Lymphoma Treatment in Japan